We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

164 hedge funds and large institutions have $454M invested in Viking Therapeutics in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more call options, than puts

Call options by funds: $29.3M | Put options by funds: $18M

31% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 45

26% more capital invested

Capital invested by funds: $360M → $454M (+$94.8M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.27% less ownership

Funds ownership: 65.79% → 63.51% (-2.3%)

2% less funds holding

Funds holding: 168 → 164 (-4)

13% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 30

Holders
164
Holders Change
-4
Holders Change %
-2.38%
% of All Funds
3.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
59
Reduced
45
Closed
30
Calls
$29.3M
Puts
$18M
Net Calls
+$11.3M
Net Calls Change
+$9.45M

Top Buyers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
+$6.78M
2
ACH
ArrowMark Colorado Holdings
Colorado
+$5.87M
3
SSA
Schonfeld Strategic Advisors
New York
+$5.48M
4
Bank of America
Bank of America
North Carolina
+$5.42M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.36M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.6M
2
Citigroup
Citigroup
New York
-$7.4M
3
SFM
Sphera Funds Management
Israel
-$5.71M
4
PM
Prosight Management
Texas
-$4.77M
5
Two Sigma Investments
Two Sigma Investments
New York
-$2.98M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
51
Morgan Stanley
New York
$1.44M -$2.21M -264,156 -65%
NTC
52
NF Trinity Capital
Hong Kong
$1.39M – – –
Charles Schwab
53
Charles Schwab
California
$1.34M +$45.8K +5,473 +4%
FPC
54
Falcon Point Capital
California
$1.18M +$20K +2,395 +2%
Swiss National Bank
55
Swiss National Bank
Switzerland
$1.17M +$46.9K +5,600 +5%
Invesco
56
Invesco
Georgia
$1.14M -$131K -15,681 -12%
TCM
57
Tekla Capital Management
Massachusetts
$1.13M +$477K +57,008 +100%
TCIM
58
TIAA CREF Investment Management
New York
$1.06M +$67K +8,004 +8%
HCMT
59
Highland Capital Management (Texas)
Texas
$1.02M – – –
Wellington Management Group
60
Wellington Management Group
Massachusetts
$1.01M +$521K +62,236 +157%
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$933K – – –
Parallax Volatility Advisers
62
Parallax Volatility Advisers
California
$908K +$537K +64,132 +236%
MWNA
63
Marshall Wace North America
New York
$880K +$741K +88,573 New
ERSOT
64
Employees Retirement System of Texas
Texas
$835K – – –
State of Wisconsin Investment Board
65
State of Wisconsin Investment Board
Wisconsin
$816K +$239K +28,600 +53%
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$773K +$42K +5,017 +7%
Bank of Montreal
67
Bank of Montreal
Ontario, Canada
$761K +$172K +20,600 +37%
Group One Trading
68
Group One Trading
Illinois
$748K -$1M -119,988 -61%
AllianceBernstein
69
AllianceBernstein
Tennessee
$699K +$33.5K +4,000 +6%
FAM
70
Fred Alger Management
New York
$676K +$335K +40,000 +143%
Goldman Sachs
71
Goldman Sachs
New York
$648K -$1.3M -155,253 -70%
Balyasny Asset Management
72
Balyasny Asset Management
Illinois
$613K -$2.53M -301,948 -83%
FI
73
Fosun International
China
$589K – – –
TAM
74
Tocqueville Asset Management
New York
$575K +$136K +16,300 +39%
Citigroup
75
Citigroup
New York
$557K -$7.4M -883,613 -94%
1 2
3
4 5

VKTX Hedge Fund Activity: Q1 2019 in Review

164 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q1 2019, worth a combined $454M — up 26% from $360M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of VKTX and 26 opened new positions — a net loss of 4 holders — while 45 trimmed existing stakes and 59 added.

The largest buyer was Rubric Capital Management (New York), opening a new position worth an estimated $6.78M. The largest seller was Fidelity Investments, cutting an estimated $16.6M.

  • 164 institutional investors held Viking Therapeutics (VKTX) as of Q1 2019, down from 168 in Q4 2018.
  • Funds reported $454M of Viking Therapeutics stock for Q1 2019, up 26% quarter-over-quarter.
  • 26 funds opened new Viking Therapeutics positions in Q1 2019 and 30 closed out, a net change of -4 holders.
  • The largest Viking Therapeutics buyer in Q1 2019 was Rubric Capital Management (New York), an estimated $6.78M added.
  • The largest Viking Therapeutics seller in Q1 2019 was Fidelity Investments, an estimated $16.6M sold.

Based on aggregated 13F filings for Q1 2019.